GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Cyclically Adjusted FCF per Share

China Pharma Holding (STU:XQJ0) Cyclically Adjusted FCF per Share : €4.82 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

China Pharma Holding's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.041. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €4.82 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of China Pharma Holding was 28.30% per year. The lowest was 9.70% per year. And the median was 20.50% per year.

As of today (2024-06-07), China Pharma Holding's current stock price is €2.68. China Pharma Holding's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €4.82. China Pharma Holding's Cyclically Adjusted Price-to-FCF of today is 0.56.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Pharma Holding was 1.14. The lowest was 0.48. And the median was 0.77.


China Pharma Holding Cyclically Adjusted FCF per Share Historical Data

The historical data trend for China Pharma Holding's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Cyclically Adjusted FCF per Share Chart

China Pharma Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.01 -0.78 -0.90 -0.91 1.99

China Pharma Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.50 -1.24 -0.51 1.99 4.82

Competitive Comparison of China Pharma Holding's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Pharma Holding's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's Cyclically Adjusted Price-to-FCF falls into.



China Pharma Holding Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China Pharma Holding's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.041/115.2271*115.2271
=-0.041

Current CPI (Mar. 2024) = 115.2271.

China Pharma Holding Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.732 98.200 -0.859
201409 -0.139 98.900 -0.162
201412 0.944 99.000 1.099
201503 -0.052 99.900 -0.060
201506 -0.747 99.500 -0.865
201509 1.148 100.500 1.316
201512 0.726 100.600 0.832
201603 1.302 102.200 1.468
201606 -0.791 101.400 -0.899
201609 0.865 102.400 0.973
201612 1.486 102.600 1.669
201703 -0.018 103.200 -0.020
201706 -0.825 103.100 -0.922
201709 0.638 104.100 0.706
201712 0.842 104.500 0.928
201803 0.484 105.300 0.530
201806 -0.417 104.900 -0.458
201809 0.865 106.600 0.935
201812 0.862 106.500 0.933
201903 -0.314 107.700 -0.336
201906 0.392 107.700 0.419
201909 0.487 109.800 0.511
201912 -0.075 111.200 -0.078
202003 -0.615 112.300 -0.631
202006 -0.409 110.400 -0.427
202009 -0.470 111.700 -0.485
202012 0.534 111.500 0.552
202103 -0.255 112.662 -0.261
202106 0.615 111.769 0.634
202109 -0.416 112.215 -0.427
202112 -0.183 113.108 -0.186
202203 -0.844 114.335 -0.851
202206 -0.497 114.558 -0.500
202209 -0.035 115.339 -0.035
202212 0.448 115.116 0.448
202303 -0.170 115.116 -0.170
202306 -0.100 114.558 -0.101
202309 0.357 115.339 0.357
202312 -0.002 114.781 -0.002
202403 -0.041 115.227 -0.041

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


China Pharma Holding  (STU:XQJ0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

China Pharma Holding's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.68/4.82
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Pharma Holding was 1.14. The lowest was 0.48. And the median was 0.77.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


China Pharma Holding Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China Pharma Holding (STU:XQJ0) Business Description

Traded in Other Exchanges
Address
Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines